TGFB2 and metastatic neoplasm: The difference in location of a metastatic tumor was likely due to the expression of transforming growth factor-beta 2 (TGF-β2) in melanoma cells: TGF-β2 mRNA was highly expressed by the K-1735 cells, whereas the B16 cells or B16 x K-1735 cell mixes had low expression.